Our partner is a clinical-stage biotechnology company focused on delivering novel therapies for autoimmune diseases with the heaviest patient burdens. They are rapidly developing a pipeline of medicines targeted to the specific molecular dysregulations underlying severe autoimmune conditions, unlocking new treatment options for patients who are underserved by existing therapies.

This critical hire was responsible for managing the regulatory operations infrastructure and overseeing the regulatory publishing and document management needs. They oversaw all regulatory operations activities for the programs including document archiving, submissions planning, publishing, QC, and submissions management.